Qt Imaging Holdings (QTI) Cash from Restructuring (2024)

Qt Imaging Holdings' (QTI) quarterly Cash from Restructuring came in at -$20349.0 in Q4 2024, down 656.74% on a QoQ basis from $3655.0 in Q2 2024.

Qt Imaging Holdings (QTI) Cash from Restructuring (2024) Analysis & Trends

Qt Imaging Holdings (QTI) has 1 years of Cash from Restructuring data on file, last reported at -$20349.0 in Q4 2024.

On a quarterly basis, Cash from Restructuring changed N/A year-over-year to -$20349.0 in Q4 2024; TTM through Sep 2025 was -$20349.0, a 100.55% decrease from a year earlier, with the FY2024 full-year figure at $3.7 million, changed N/A from the prior year.
Cash from Restructuring for Q4 2024 stood at -$20349.0, down from $3655.0 in the prior quarter.
Over the last five years, Cash from Restructuring for QTI reached as high as $3.7 million in Q1 2024 and fell as low as -$20349.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Qt Imaging Holdings	33.72 Mn	26.82 Mn	2.67 Mn

Download Data